{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:15:43Z","timestamp":1791231343590,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06054-3","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T23:08:48Z","timestamp":1741129728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the safety of doxapram in premature neonates born before 28\u00a0weeks of gestation"],"prefix":"10.1007","volume":"184","author":[{"given":"Lauren","family":"Saade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Zana-Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Henri","family":"Jarreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Biran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Loukil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Tr\u00e9luyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lo\u00efse","family":"Torchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"1","key":"6054_CR1","doi-asserted-by":"publisher","first-page":"e21783","DOI":"10.7759\/cureus.21783","volume":"14","author":"J Pergolizzi","year":"2022","unstructured":"Pergolizzi J, Kraus A, Magnusson P et al (2022) Treating apnea of prematurity. Cureus 14(1):e21783. https:\/\/doi.org\/10.7759\/cureus.21783","journal-title":"Cureus"},{"issue":"1","key":"6054_CR2","doi-asserted-by":"publisher","first-page":"e20153757","DOI":"10.1542\/peds.2015-3757","volume":"137","author":"EC Eichenwald","year":"2016","unstructured":"Eichenwald EC, Committee on Fetus and Newborn, Watterberg KL et al (2016) Apnea of prematurity. Pediatrics 137(1):e20153757. https:\/\/doi.org\/10.1542\/peds.2015-3757","journal-title":"Pediatrics"},{"key":"6054_CR3","doi-asserted-by":"publisher","unstructured":"Henderson\u2010Smart DJ, Paoli AGD (2010) Methylxanthine treatment for apnoea in preterm infants - Henderson\u2010Smart, DJ - 2010 | Cochrane Library. Accessed August 27, 2024. https:\/\/doi.org\/10.1002\/14651858.CD000140.pub2\/full","DOI":"10.1002\/14651858.CD000140.pub2\/full"},{"issue":"4","key":"6054_CR4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S0022-3476(05)81620-8","volume":"116","author":"A Peliowski","year":"1990","unstructured":"Peliowski A, Finer NN (1990) A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J Pediatr 116(4):648\u2013653. https:\/\/doi.org\/10.1016\/S0022-3476(05)81620-8","journal-title":"J Pediatr"},{"issue":"11","key":"6054_CR5","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1080\/080352598750031185","volume":"87","author":"C Huon","year":"1998","unstructured":"Huon C, Rey E, Mussat P, Parat S, Moriette G (1998) Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants: a randomized, double-blind study. Acta Paediatr 87(11):1180\u20131184. https:\/\/doi.org\/10.1080\/080352598750031185","journal-title":"Acta Paediatr"},{"key":"6054_CR6","doi-asserted-by":"publisher","unstructured":"Henderson-Smart DJ, Steer PA (2000) Doxapram versus methylxanthine for apnea in preterm infants. Cochrane Neonatal Group (ed) Cochrane Database of Systematic Reviews. Published online October 23, 2000. https:\/\/doi.org\/10.1002\/14651858.CD000075","DOI":"10.1002\/14651858.CD000075"},{"issue":"1","key":"6054_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0022-3476(86)80786-7","volume":"108","author":"KJ Barrington","year":"1986","unstructured":"Barrington KJ, Finer NN, Peters KL, Barton J (1986) Physiologic effects of doxapram in idiopathic apnea of prematurity. J Pediatr 108(1):124\u2013129. https:\/\/doi.org\/10.1016\/s0022-3476(86)80786-7","journal-title":"J Pediatr"},{"key":"6054_CR8","doi-asserted-by":"publisher","unstructured":"Tr\u00e9luyer L, Zana-Taieb E, Jarreau PH et al (2024) Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5\u20136 years. Arch Dis Child Fetal Neonatal Ed. Published online January 16, 2024:fetalneonatal-2023\u2013326170. https:\/\/doi.org\/10.1136\/archdischild-2023-326170","DOI":"10.1136\/archdischild-2023-326170"},{"issue":"8\u20139","key":"6054_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1651-2227.1991.tb11949.x","volume":"80","author":"H Kumita","year":"1991","unstructured":"Kumita H, Mizuno S, Shinohara M, Ichikawa T, Yamazaki T (1991) Low-dose doxapram therapy in premature infants and its CSF and serum concentrations. Acta Paediatr Scand 80(8\u20139):786\u2013791. https:\/\/doi.org\/10.1111\/j.1651-2227.1991.tb11949.x","journal-title":"Acta Paediatr Scand"},{"issue":"4","key":"6054_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000243342","volume":"59","author":"J Tay-Uyboco","year":"1991","unstructured":"Tay-Uyboco J, Kwiatkowski K, Cates DB, Seifert B, Hasan SU, Rigatto H (1991) Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Biol Neonate 59(4):190\u2013200. https:\/\/doi.org\/10.1159\/000243342","journal-title":"Biol Neonate"},{"issue":"2","key":"6054_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000448941","volume":"111","author":"RJS Vliegenthart","year":"2017","unstructured":"Vliegenthart RJS, ten Hove CH, Onland W, van Kaam AHLC (2017) Doxapram treatment for apnea of prematurity: a systematic review. Neonatology 111(2):162\u2013171. https:\/\/doi.org\/10.1159\/000448941","journal-title":"Neonatology"},{"issue":"4","key":"6054_CR12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1542\/peds.75.4.709","volume":"75","author":"F Eyal","year":"1985","unstructured":"Eyal F, Alpan G, Sagi E et al (1985) Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study. Pediatrics 75(4):709\u2013713","journal-title":"Pediatrics"},{"issue":"6","key":"6054_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.siny.2018.07.005","volume":"23","author":"AT Rose","year":"2018","unstructured":"Rose AT, Patel RM (2018) A critical analysis of risk factors for necrotizing enterocolitis. Semin Fetal Neonatal Med 23(6):374\u2013379. https:\/\/doi.org\/10.1016\/j.siny.2018.07.005","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3","key":"6054_CR14","doi-asserted-by":"publisher","first-page":"e0194352","DOI":"10.1371\/journal.pone.0194352","volume":"13","author":"M Ahle","year":"2018","unstructured":"Ahle M, Drott P, Elfvin A, Andersson RE (2018) Maternal, fetal and perinatal factors associated with necrotizing enterocolitis in Sweden. A national case-control study. PLoS One 13(3):e0194352. https:\/\/doi.org\/10.1371\/journal.pone.0194352","journal-title":"PLoS One"},{"issue":"3","key":"6054_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/jp.2011.65","volume":"32","author":"RH Clark","year":"2012","unstructured":"Clark RH, Gordon P, Walker WM, Laughon M, Smith PB, Spitzer AR (2012) Characteristics of patients who die of necrotizing enterocolitis. J Perinatol 32(3):199\u2013204. https:\/\/doi.org\/10.1038\/jp.2011.65","journal-title":"J Perinatol"},{"issue":"1","key":"6054_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"MJ Bell","year":"1978","unstructured":"Bell MJ, Ternberg JL, Feigin RD et al (1978) Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 187(1):1\u20137","journal-title":"Ann Surg."},{"issue":"6","key":"6054_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","volume":"200","author":"EA Jensen","year":"2019","unstructured":"Jensen EA, Dysart K, Gantz MG et al (2019) The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 200(6):751\u2013759. https:\/\/doi.org\/10.1164\/rccm.201812-2348OC","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"6054_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 92(4):529\u2013534. https:\/\/doi.org\/10.1016\/s0022-3476(78)80282-0","journal-title":"J Pediatr"},{"issue":"2","key":"6054_CR19","doi-asserted-by":"publisher","first-page":"F182","DOI":"10.1136\/archdischild-2017-313880","volume":"103","author":"C Battersby","year":"2018","unstructured":"Battersby C, Santhalingam T, Costeloe K, Modi N (2018) Incidence of neonatal necrotising enterocolitis in high-income countries: a systematic review. Arch Dis Child Fetal Neonatal Ed 103(2):F182\u2013F189. https:\/\/doi.org\/10.1136\/archdischild-2017-313880","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6054_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2431-14-97","volume":"14","author":"PY Ancel","year":"2014","unstructured":"Ancel PY, Goffinet F (2014) EPIPAGE 2: a preterm birth cohort in France in 2011. BMC Pediatr 14:97. https:\/\/doi.org\/10.1186\/1471-2431-14-97","journal-title":"BMC Pediatr"},{"issue":"1","key":"6054_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000444006","volume":"110","author":"CH ten Hove","year":"2016","unstructured":"ten Hove CH, Vliegenthart RJ, te Pas AB et al (2016) Long-term neurodevelopmental outcome after doxapram for apnea of prematurity. Neonatology 110(1):21\u201326. https:\/\/doi.org\/10.1159\/000444006","journal-title":"Neonatology"},{"issue":"4","key":"6054_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000014160","volume":"76","author":"CF Poets","year":"1999","unstructured":"Poets CF, Darraj S, Bohnhorst B (1999) Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants. Biol Neonate 76(4):207\u2013213. https:\/\/doi.org\/10.1159\/000014160","journal-title":"Biol Neonate"},{"key":"6054_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/251047","volume":"2013","author":"SA Prins","year":"2013","unstructured":"Prins SA, Pans SJA, van Weissenbruch MM, Walther FJ, Simons SHP (2013) Doxapram use for apnoea of prematurity in neonatal intensive care. Int J Pediatr 2013:1\u20135. https:\/\/doi.org\/10.1155\/2013\/251047","journal-title":"Int J Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06054-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06054-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06054-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T13:03:51Z","timestamp":1743080631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06054-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["6054"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06054-3","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the local ethical standards (Comit\u00e9 d'Evaluation de l'Ethique des Projets de Recherche de Robert Debr\u00e9).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}